TI TARGET Trademark

Trademark Overview

On Tuesday, March 1, 2016, a trademark application was filed for TI TARGET with the United States Patent and Trademark Office. The USPTO has given the TI TARGET trademark a serial number of 86925002. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 21, 2024. This trademark is owned by QPharma, Inc.. The TI TARGET trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Technology solution for life sciences companies, namely, providing temporary use of non-downloadable computer software for analyzing physician and healthcare practitioner demographics, for analyzing prescribing activity, for analyzing influence networks, namely, identifying influential healthcare specialists and physicians, and for analyzing other business intelligence criteria, namely, medical science liaison (MSL) initiatives between MSLs and pharmaceutical and life sciences clients, all the foregoing used to enable effective customer targeting in support of promotional and outreach activities; services associated Technology solutions, namely, information technology (IT) consultation
ti target

General Information

Serial Number86925002
Word MarkTI TARGET
Filing DateTuesday, March 1, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 21, 2024
Registration Number5351210
Registration DateTuesday, December 5, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2017

Trademark Statements

NOT AVAILABLE"TARGET"
Goods and ServicesTechnology solution for life sciences companies, namely, providing temporary use of non-downloadable computer software for analyzing physician and healthcare practitioner demographics, for analyzing prescribing activity, for analyzing influence networks, namely, identifying influential healthcare specialists and physicians, and for analyzing other business intelligence criteria, namely, medical science liaison (MSL) initiatives between MSLs and pharmaceutical and life sciences clients, all the foregoing used to enable effective customer targeting in support of promotional and outreach activities; services associated Technology solutions, namely, information technology (IT) consultation

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 21, 2024
Primary Code042
First Use Anywhere DateThursday, March 24, 2016
First Use In Commerce DateThursday, March 24, 2016

Trademark Owner History

Party NameQPharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameQPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameQPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960

Trademark Events

Event DateEvent Description
Tuesday, June 14, 2016ASSIGNED TO EXAMINER
Saturday, March 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 15, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 16, 2016NON-FINAL ACTION WRITTEN
Thursday, June 16, 2016NON-FINAL ACTION E-MAILED
Thursday, June 16, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 31, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 8, 2016ASSIGNED TO LIE
Thursday, September 15, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 15, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 15, 2016NON-FINAL ACTION WRITTEN
Thursday, September 15, 2016NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 11, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 23, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 21, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 21, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, February 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 3, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 23, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 1, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 5, 2017REGISTERED-PRINCIPAL REGISTER
Monday, December 5, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 21, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, October 31, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 11, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 12, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, October 12, 2017USE AMENDMENT FILED
Tuesday, October 24, 2017STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

target namely analyzing technology healthcare life sciences clients pharmaceutical used enable